FDA-Drug2026-08-19Class IIPROCESSING DEFECT
Novartis Diovan 160 mg tablets recalled for failed dissolution specifications
What this means
One lot of Novartis Diovan (valsartan) 160 mg tablets failed to meet dissolution specifications, which means the tablets may not dissolve properly in the body. This could affect how well the medication works. The affected lot (AV5913C, expiring 6/2027) was distributed nationwide.
- Check your Diovan bottle for lot number AV5913C and expiration date of 6/2027.
- If you have this lot, contact your pharmacy or doctor before stopping your medication.
- Do not stop taking your blood pressure medication without medical guidance.
The agency's original wording
Hazard
Failed Dissolution Specifications
Intended for
Adults
Illnesses reported
None reported
Sold states
US Nationwide
Manufactured in
1 Health Plz, East Hanover, NJ, United States
Products
Diovan (valsartan) 160 mg, 90 tablets, Rx only, Manufactured by: Patheon Manufacturing Services LLC, Greenville, NC 27834, Distributed by: Novartis Pharmaceutical Corp, East Hanover, NJ 07936, NDC 0078-0359-34
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0746-2026Want us to check the next one for you?
We read every CPSC, FDA, USDA, and NHTSA notice and email you a plain-English Sunday brief covering your household — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.